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ORIGINAL ARTICLES
Extending the Minimum Information
About BIobank Data Sharing Terminology
to Describe Samples, Sample Donors, and Events
Niina Eklund,1 Ny Haingo Andrianarisoa,2 Esther van Enckevort,3 Gabriele Anton,4 Annelies Debucquoy,5
Heimo Müller,6 Linda Zaharenko,7 Cäcilia Engels,8 Lars Ebert,9 Michael Neumann,10 Joachim Geeraert,11
Veronique T’Joen,11 Hans Demski,4 Élodie Caboux,2 Rumyana Proynova,9 Barbara Parodi,12 Sebastian Mate,13
Erik van Iperen,14 Roxana Merino-Martinez,15 Philip R. Quinlan,16 Petr Holub,17 and Kaisa Silander1
Introduction: The Minimum Information About BIobank data Sharing (MIABIS) was initiated in 2012.
MIABIS aims to create a common biobank terminology to facilitate data sharing in biobanks and sample
collections. The MIABIS Core terminology consists of three components describing biobanks, sample collec-
tions, and studies, in which information on samples and sample donors is provided at aggregated form.
However, there is also a need to describe samples and sample donors at an individual level to allow more
elaborate queries on available biobank samples and data. Therefore the MIABIS terminology has now been
extended with components describing samples and sample donors at an individual level.
Materials and Methods: The components were defined according to specific scope and use cases by a large
group of experts, and through several cycles of reviews, according to the new MIABIS governance model of
BBMRI-ERIC (Biobanking and Biomolecular Resources Research Infrastructure–European Research Infra-
structure Consortium). The guiding principles applied in developing these components included the following
terms: model should consider only samples of human origin, model should be applicable to all types of samples
and all sample donors, and model should describe the current status of samples stored in a given biobank.
Results: A minimal set of standard attributes for defining samples and sample donors is presented here. We
added an ‘‘event’’ component to describe attributes that are not directly describing samples or sample donors
but are tightly related to them. To better utilize the generic data model, we suggest a procedure by which
interoperability can be promoted, using specific MIABIS profiles.
Discussion: The MIABIS sample and donor component extensions and the new generic data model comple-
ment the existing MIABIS Core 2.0 components, and substantially increase the potential usability of this
terminology for better describing biobank samples and sample donors. They also support the use of individual
level data about samples and sample donors to obtain accurate and detailed biobank availability queries.
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Introduction
The concept of Minimum Information About BIobankdata Sharing (MIABIS) was originally developed in
2012 by the Biobanking and BioMolecular Resources Re-
search Infrastructure of Sweden to facilitate biobank and
sample collection data sharing.1 MIABIS Core, further up-
dated to version 2 in 2016, consists of components defining
biobanks, collections, and studies on an aggregated level.2
The first version of MIABIS Core was ontologized in 2013
and is referred to as Ontologized MIABIS (OMIABIS).3 It
was later combined with another biobanking ontology
forming the current Ontology for biobanking (OBIB).4 The
use of ontologies facilitates integration of data from multi-
ple sources. The integrated data can then be used for re-
trieving data in queries in a structured and organized
form.3,4 The ontologization of MIABIS Core version 2.0 is
almost complete and the new ontologized attributes are
available through OBIB. The MIABIS Core version 2.0 is
currently used in different biobank registers and catalogs,
that is, in the Biobanking and Biomolecular Resources Re-
search Infrastructure–European Research Infrastructure
Consortium (BBMRI-ERIC) Directory5 and the U.K. Clin-
ical Research Collaboration (UK CRC) Tissue Directory,6
and is implemented as part of data models for biobank and
research information management systems such as Mol-
genis.7 The development of MIABIS is currently coordi-
nated by the Common Service IT (CS IT) operations of
BBMRI-ERIC.8
Different organizations and research infrastructures9–12
have previously undertaken steps to allow data from mul-
tiple studies to be aggregated and made available for reuse
and sharing for other purposes. In addition, several initia-
tives have focused on standardization of the collection of
data and their definitions by use of ontologies and bio-
medical standards.3,4,13–16 Although these initiatives and
organizations have made relevant progress in their area of
expertise, the produced reference terminologies are often
too specific for the intended designed needs or too elaborate
and are thus not generic enough to cover cases outside their
original focus.
The aim of this study was to extend the MIABIS stan-
dard by describing sample donors (research participant/
patient/donor) and samples at an individual level, thus ex-
tending the aggregated view provided by the MIABIS Core
components. The work is based on several use-cases from the
field of biobanking, which have the following in common: the
sharing of individual-level data about samples and sample
donors to support interoperability between biobanks/cata-
logs, and to enable availability queries for suitable samples.
Materials and Methods
Defining the scope of work and collecting use-cases
The guiding principles used for developing the MIABIS
Sample and Sample Donor components were laid out by a
small team of experts from BBMRI-ERICs CS IT, and the
work plan was approved by BBMRI-ERICs Management
Committee.
Six distinctive guiding principles were established as the
foundation for the Sample and Sample Donor component
definition work:
1. The components are aimed only at samples of human
origin.
2. The components are applicable to all types of samples
and all sample donors (i.e., no sample-type-specific
attributes), as extensions can later be introduced by
domain-specific MIABIS modules.
3. Hierarchical structures between the different attributes
in a component are not defined within MIABIS, except
for basic attributes that link the components and spe-
cific structured attributes. Each use-case and each in-
frastructure can define the data structure as needed for
their own purpose.
4. The sample component aims to capture information on
the current status of samples stored in a given biobank.
Sample handling and processing history are not in-
cluded in this study.
5. Each component is independent and searchable on its
own. There are no dependencies with other information
sources, except between sample and sample donor.
6. Predefined data terminologies are used if they exist,
including attributes already defined for the MIABIS
Core 2.0, which could also be used for describing
individual-level data.
After the guiding principles for the MIABIS extension
were established, use-cases for developing the Sample and
Sample Donor components were requested by BBMRI-
ERIC from their representative National Nodes. In total, five
use-cases were identified, on which we based the develop-
ment work:
1. BBMRI-ERICs Sample Locator8 is a federated query
tool that enables researchers to query biobanks’
individual-level data stored in the Connectors of in-
dividual biobanks to find biobanks that host samples
and/or sample-related data that comply with the re-
searcher’s needs. The MIABIS Sample and Sample
Donor component will form the common data model
for the Connectors, whereas the federated querying
interface providing aggregate responses to the queries
is beyond the scope of this article.
2. Vendor-Neutral Sample Exchange Format: The UK
CRC Tissue Directory6 aims to help researchers to find
suitable samples for their research related to different
diseases. By defining a vendor-neutral data exchange
format, the transfer of sample information is allowed
between different software solutions, which can orig-
inate from open source and commercial vendors.
3. RD-Connect17 is a global infrastructure project that
links up databases, registries, biobanks, and clinical
bioinformatics data used in rare disease research into a
central resource for researchers worldwide.
4. Amsterdam UMC Biobank18 is a university hospital
biobank, located at Amsterdam Medical Centers,
Amsterdam, the Netherlands, aiming to create a cata-
log based on sample-level data to make its samples
findable and accessible (FAIR principles19).
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5. German Biobank Alliance20 aims to establish the
technical prerequisites and IT tools for a consistent
search, application, and joint use of biosamples
throughout Germany.
The use-cases were used in defining the scope and re-
quirements of the work, and in selecting and defining the
attributes, which best describe sample donors and samples at
an individual level.
Governance model and review process
The MIABIS Sample and Sample Donor development
work followed a new governance model. In this model the
MIABIS development work is distributed into dedicated
working groups that specify the components for specific
extensions and modules. Each module has an initial scope of
work as part of its setup process. The scope of each module
is defined through specified use-cases. Before a working
group can initiate the development work, BBMRI-ERICs
Management Committee approves the suggested scope and
work plan of the module. Once the working group has
produced the finalized suggestion, the extension module
goes through an extensive iterative review process by ex-
ternal experts selected by BBMRI-ERIC until all the com-
ments have been addressed thoroughly. The finalized
suggestion is submitted to the Management Committee of
BBMRI-ERIC for approval. For the work on the MIABIS
extension described in this study, we followed this new
MIABIS governance model.
Development of the components
The extension work of MIABIS was coordinated by the
Finnish Institute for Health and Welfare, and it followed
similar working principles as described for the development
of the MIABIS Core 2.0.2 The development work included
thorough discussion through web meetings and e-mail, using
a joint Wiki page for distributing the working materials. The
draft suggestion for component attributes was based on a
consensus achieved during the development work. We
aimed to implement the modularity of different components
defined already in MIABIS Core,1,2 and therefore existing
attributes were used whenever possible.
The draft suggestion of MIABIS Sample and Sample
Donor components was sent to various experts for review
regarding the content and description of the attributes.
Feedback was received from biobanking and IT experts
from Belgium, Finland, Germany, Latvia, Malta, and the
Netherlands. The updated proposal was submitted for fur-
ther review by BBMRI-ERIC to several domain experts.
Based on the expert panel’s comments, obtained during
January to February 2018, the proposal was revised fol-
lowing a new round of web meetings and e-mail discussions.
The current proposal was approved by the BBMRI-ERIC
Management Committee in April 2019.
Results
The current extension describes a minimal set of standard
attributes for defining samples and individuals (research
participants, donors, or patients), further denoted as sample
donors. We suggest registering time-linked attributes that
are related to the sample or sample donor through separate
Event components. These attributes can be, for example,
different observations with time stamps related to them. The
Event components can then be linked to the sample and/or to
the sample donor, allowing for modeling context, that is,
describing the circumstances that form the settings of events
related to the sample/sample donor. Defining the concept of
Events is a common approach used in clinical models such as
Fast Healthcare Interoperability Resources (FHIR) created
by Health Level 7 International (HL7)21 or OpenEHR,22
which is an open platform for industry specifications, models,
and software for e-health.
Sample donor, sample, and event components
and their attributes
MIABIS 2.0 Core was extended with independent com-
ponents describing individual-level information on Sample
Donor, Sample, and a generic template for Event with a few
case examples of use. The new MIABIS components were
defined as follows:
1. Sample donor is a person who is a source of either a
biological material or a digital representation of a
biological entity such as an image. The existing
OMIABIS definition for a sample donor was mod-
ified based on the Merriam-Webster Dictionary
definition.23,24
2. A sample is a portion or quantity of biological material
that is collected from a sample donor, or which is a
digital representation of a biological entity of the sam-
ple donor, such as an image. The existing OMIABIS
definition for a sample was extended based on the
Merriam-Webster Dictionary definition.23,25
3. An event is something that happens in a given place
and time and is related to the sample and/or sample
donor. The definition was created based on the NCI
Thesaurus.26
After the components were identified and defined, attri-
butes to be included in the new components were described
and organized to where they would fit best. The modular
structure of MIABIS defined in the MIABIS 2.0 Core work2
was maintained. The suggested attributes for each compo-
nent are presented in Tables 1–3.
Tables 1–3 describe the detailed attribute and data item
lists for Sample Donor, Sample, and Event components.
The Sample component (Table 2) attributes Detailed
Sample Type and Sample Storage Temperature are based on
the Sample PREanalytical Code (SPREC), version 327,28
standard with certain modifications and additions. The
SPREC (version 3) attribute Type of sample was used to
establish the initial list of values for the new MIABIS at-
tribute Detailed sample type. Because SPREC includes
only information on primary samples, we have added sev-
eral values for processed samples that are commonly stored
in biobanks, such as DNA and RNA, as well as the values
Digital sample and Postmortem sample. We also edited the
SPREC value list to omit information on sample processing
method, which is not part of MIABIS. For example, the
SPREC values Plasma, single spun and Plasma, double
spun have been merged into a single value Plasma in
MIABIS. Finally, we added a new structured attribute,
Anatomical site, to provide information about the anatom-
ical source of the sample material.






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































We also suggest an attribute called Sample content di-
agnosis, which reflects the content of the sample, that is,
whether the sample contains cancerous tissue or not or
whether the sample is taken from a tissue that is affected by
a given disease. The Sample content diagnosis should con-
tain the specific disease code/s if the sample is taken from a
tumor and contains cancerous cells, or from a tissue that is
affected by a disease.
All the components presented in Tables 1–3 can be
readily used. However, some attributes allowing multiple
values to be recorded for one item might require additional
processing when implemented in database solutions. Such
an example is presented in Supplementary Table S1, where
each allowed value for MIABIS Sample component attribute
Use restrictions is tabulated as an independent attribute
receiving values Yes/No/Not applicable. In addition, the
Event component is a generic template comprising only of
the minimal items that should always be registered for an
event (Table 3), and it should be complemented by carefully
selected event-specific attributes. In this study, the Event com-
ponent is kept short on purpose, because of plethora of different
event types. To keep the MIABIS terminology and data model
as general as possible, we only created a generic template for
Events that can be used to define specific events for different
purposes. To demonstrate the use of the Event component, we
describe three use-case examples for events: Sampling Event,
Disease Diagnosis Event, and Death Event, which are presented
in Supplementary Tables S2–S4.
Changes in MIABIS structure
to enhance interoperability
Along with the MIABIS extension, a generic data model
to support interoperability between biobanks sharing their
individual-level data on samples and sample donors is
suggested (Fig. 1). The data model was held very generic to
ensure its usability for a variety of use-cases. To facilitate
interoperability between information systems using MIA-
BIS, and to add measures to improve their technical im-
plementations, we suggest using use-case-specific profiles.
These profiles may apply different restrictions in local im-
plementations of the MIABIS data model. The profiles can
enforce additional restrictions on relations to entities and
turn some entities mandatory. For example, a profile can
define 1.n cardinality, where the generic model only de-
fines 0.n, such as requiring that for each sample minimal
information on sample donor must also be provided, or a
profile can include fixed or restricted values for an attri-
butes, such as requiring that the sample donor’s age is given
in years.
To ensure that all use-cases are able to implement the
MIABIS data model and can map their data to it without
imposing any need for additional adjustments, we have used
unique identifiers for each attribute and a component-
specific prefix. Furthermore, for each attribute only one value
is allowed. An example on tabulating list items as indepen-
dent attributes is presented in Supplementary Table S1.
Synchronization with MIABIS Core
The development of MIABIS Sample and Sample Donor
components resulted in several small changes in MIABIS
Core attributes, such as in Data categories, where new types
of data were inserted, and Sample storage temperature,
where the value Liquid nitrogen vapor phase was introduced
to better distinguish the different temperature ranges asso-
ciated with liquid nitrogen. Other changes include the cod-
ing scheme of attributes and adjustments in the data model.
Furthermore, with the latest component additions, MIABIS
is heavily focused around biological samples. However,
some biobanks may not have biological samples, but are
rather built around data. Such data-driven biobanks are be-
coming more common while biobank samples are converted
into data, and new digital sample types emerge through
biological imaging techniques. Thus, the concepts digital
samples and data-driven biobanks need to be accommo-
dated. Owing to these reasons, MIABIS Core is currently
being updated into its third version, and work on this was
initiated in May 2019.
Discussion
The MIABIS Sample donor, Sample, and Event compo-
nents were defined according to a specific scope and use-
Table 3. Generic Structure for Creating Event Records
Attribute code Attribute name Allowed values Attribute description Constraints Cardinality
MIABIS-
EVENT-01
Event ID Coded String Random ID for each
event, created by the
database
implementation







yyyy-mm-ddThh:mm:ss The date and time




Use either age at event
or event date and
time, not both. Date
of birth is required





Age at event Decimal Age at the time of the
event
Use either age at event










Unit defining age at
event
When age at event is
provided, age unit is
required
0
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FIG. 1. The generic data model for the MIABIS ‘‘Sample,’’ ‘‘Sample Donor,’’ and ‘‘Event’’ components, and how it is
linked with the MIABIS Core components ‘‘Sample Collection’’ and ‘‘Biobank.’’ This diagram uses the Crow’s foot
notation. Different types of events can be linked to the model. Examples of these events are connected to the generic event
with dashed lines, and they can be used to replace the ‘‘Event’’ component, shown as a placeholder. The required attributes
in each component are marked with an asterisk. In addition, attribute ‘‘Birth date’’ in ‘‘Sample donor’’ component is
marked with a plus to better distinguish its use-case dependency and the requirement to be implemented only when, that is,
exact ‘‘Event date and time’’ attribute is used. MIABIS, Minimum Information About BIobank data Sharing.
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cases by a large group of experts, and through several
cycles of review according to the new MIABIS governance
model. The component extensions and the new generic
data model complement the existing MIABIS 2.0 Core
components, and substantially increase the potential us-
ability of this terminology for describing biobanks and
enabling searches based on individual samples. We believe
that the current MIABIS extension is consistent with the
use-cases defining the framework of the described devel-
opment work. Additional modifications to the current
MIABIS components will be carried out based on feedback
from different biobank availability services, such as Sam-
ple Locator8 and UK CRC Tissue Directory,6 which are
currently working on implementing the MIABIS profiles
for their specific use-case. The proposed model has been
used for a pilot version of the Locator service currently in
operation by the BBMRI-ERIC German National Node, to
validate the model in practical settings.
We identified attributes that were not generic enough or
were beyond the scope of this study. These attributes,
which are about sample quality and/or pre-analytical in-
formation, sample donor-related clinical data, and disease-
specific sample data, are currently listed as possible new
MIABIS extensions. However, for sample-specific pre-
analytical information there are existing standards avail-
able, which we suggest to follow: SPREC,27,28 standards
prepared by the European Committee for Standardization
(CEN) working group on Technical Specifications for Pre-
examination Processes (CEN/TC 140),29 or the Interna-
tional Organization for Standardization (ISO) standard on
Medical laboratories—Requirements for quality and com-
petence (ISO15189).30
We plan to follow the trend set by previous MIABIS work
and to ontologize the MIABIS Sample, Sample donor, and
Event components into OBIB. In addition, to increase in-
teroperability, we aim to map the MIABIS data model to
widely used electronic health resource standards, such as
FHIR,21 OpenEHR,22 or the Observational Medical Out-
comes Partnership common data model.31 Mapping MIA-
BIS to other data standards is carried out to enable the direct
use of distinct database tools together with MIABIS. Some
biobanks may have databases that are established on already
existing data standards, which is the case especially for
biobanks in hospital settings. By mapping MIABIS terms to
the existing clinical standards, the biobanks can effortlessly
produce data in MIABIS format without having to impose
large changes in their own database systems. Example for
mapping between FHIR and MIABIS is MIABIS-SAMPLE-
07, Anatomical site ontology code, which can be mapped to
FHIR term collection.bodySite.coding.code. Further map-
ping of MIABIS terminology to these clinical standards is
carried out in close collaboration with the BBMRI-ERIC
National Nodes and their specific requirements.
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